AirTight is an independent engineering team uniquely developing a novel non-invasive therapy for COVID-19 and other acute respiratory disorders. Our organization is collaborating and sponsored by clinicians from the Johns Hopkins Hospital Departments of Critical Care and Pulmonary Medicine.